Aktiva substanser | Betyg | Bibliogr. | Expandera | |
---|---|---|---|---|
1 | RNA-Binding Protein FUS | 100 | + | |
2 | Onkogenproteiner, fusion | 49 | + | |
3 | Guaninnukleotidseparationshämmare | 8 | + | |
4 | Indoler | 6 | + | |
5 | Glypikaner | 6 | + | |
6 | GTPas-aktiverande proteiner | 6 | + | |
7 | Fenylureaföreningar | 5 | + | |
8 | Kolsyreanhydras | 5 | + | |
9 | p21-Activated Kinases | 5 | + | |
10 | Platinaföreningar | 5 | + | |
11 | Pyrroler | 5 | + | |
12 | Niacinamid | 5 | + | |
13 | Annexin A4 | 5 | + | |
14 | Vacuolar Proton-Translocating ATPases | 4 | + | |
15 | Statmin | 4 | + | |
16 | Von Hippel-Lindau Tumor Suppressor Protein | 4 | + | |
17 | Bensensulfonater | 4 | + | |
18 | RNA-Binding Protein EWS | 4 | + | |
19 | Cisplatin | 3 | + | |
20 | Protonkogenproteiner c-fli-1 | 3 | + | |
21 | Mad2 Proteins | 3 | + | |
22 | rhoA GTP-bindande proteiner | 3 | + | |
23 | Pyridiner | 2 | + | |
24 | Doxorubicin | 2 | + | |
25 | Paklitaxel | 2 | + | |
26 | Dioxoler | 2 | + | |
27 | Ifosfamid | 2 | + | |
28 | Sirolimus | 2 | + | |
29 | Tumör-DNA | 2 | + | |
30 | Metylkolantren | 2 | + | |
31 | Cellkärneproteiner | 2 | + | |
32 | Vaskulär endotelcellstillväxtfaktor A | 2 | + | |
33 | Kamptotecin | 1 | + | |
34 | Interleukin-2 | 1 | + | |
35 | Karboplatin | 1 | + | |
36 | Monoklonala antikroppar | 1 | + | |
37 | Akridinorange | 1 | + | |
38 | Melfalan | 1 | + | |
39 | Daktinomycin | 1 | + | |
40 | Alfa-interferon | 1 | + | |
41 | Tetrahydroisokinoliner | 1 | + | |
42 | Mesna | 1 | + | |
43 | Receptor, IGF typ 1 | 1 | + |